Are you searching for medications to treat 'Urinary Tract Infection'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Urinary Tract Infection.

Yet these powerful molecules have three key advantages for anti-infective drug discovery ... such as peritonitis/sepsis, urinary tract infection and respiratory tract infection.

Are you searching for medications to treat 'Urinary Stone Disease'? Welcome to this page which serves as an archive for medications that are relevant to the treatment of Urinary Stone Disease.

revealing alarmingly high rates of resistance to anti-infectives ranging from first-line antibiotics used to treat urinary tract infections (UTIs) to last-resort antimicrobials used to treat a ...

The FDA has approved Allecra Therapeutics' Exblifep, a combination antibiotic for complicated urinary tract ... the development of new anti-infectives and gives the drug patent protection in ...

This medication is used to relieve the discomfort, pain, frequent urge to urinate, and cramps/spasms of the urinary tract caused by an infection or a medical procedure. To relieve dry mouth ...

The anti-infective drug market is seeing strong growth due to multiple interrelated factors. One key driver is the rising incidence of specific infectious diseases, including healthcare-associated ...

G6PD deficiency: not recommended. Allergies to foods, preservatives, or dyes. Renal disease. Discontinue and re-evaluate if symptoms persist ≥2 days. Discolors urine and fabric (red-orange).

An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary ...

The products in Uqora’s Complete Regimen are designed to work with each other to support consumers’ urinary health in multiple ways through safe, effective, high-quality ingredients ...

US and MCUG for all children aged <2 years. 99m Tc–DMSA scan in high-grade reflux [3] Urinary tract infection (UTI) is the most common serious bacterial infection in childhood, and its ...

FDA Decision Expected by PDUFA Goal Date of October 25, 2024Potential to be First Oral Penem Approved in the U.S.DUBLIN and CHICAGO, Sept. 10, ...